1. Pharma OTC & Nutrition Market Situation
MAT 2013Q2

2. Indonesia Pharmaceutical Market – MAT 2013Q2
• Indonesia is a big potential market for pharmaceutical industry, with total market size at OKU YEN 4,755 in MAT 2013Q2
• And the pharmaceutical market in Indonesia has grown rapidly at growth +12% in last year, driven by OTC sector growing +15% in
2013Q2 .
• In overall the pharmaceutical market growth is outperforming economic growth (6%).
• The market growth is expected to continue at the same rate for 2012-2015.
5,000
+12%
4,500
+14%
+11%
Sales Value Trade
OKU YEN (IDR10,583,333,333/OKU YEN)
4,000
3,500
40%
39%
+9%
39%
42%
39%
+15%
ETHICAL
+4%
1,000
60%
61%
1,500
58%
61%
+15%
500
61%
+11%
+13%
+11%
0
2010
Exchange rate: Constant IDR10,583,333,333/OKU YEN
Source: IMS Plus 2013-Q2
2011
Nutrition
OTC
+15%
2,000
2009
1
3,816
+11%
3,000
2,500
4,187
3,453
3,119
4,755
2012
2013

3. Top 20 Pharma Companies – Ethical & OTC
• Based on medication group, in average Top 5 companies in Rx and OTC are dominated by local companies, then only 3 MNCs are in
the Top 10 in Ethical market.
• Both in Rx and OTC are perfect competition market.
• Numbers of companies in Rx: 203 companies, in OTC: 186 companies.
Rank
Rx
(Ethical)
Status
IND TOTAL ETHICAL
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
KALBE GROUP
SANBE
DEXA MEDICA GROUP
NOVARTIS GROUP
SANOFI-AVENTIS GRP
FAHRENHEIT
PFIZER GROUP
KIMIA FARMA GROUP
MENSA GROUP
INDOFARMA
GLAXOSMITHKL GRP
BAYER INDONESIA
SOHO GROUP
OTSUKA GROUP
ACTAVIS
INTERBAT
DARYA-VARIA GROUP
B.INGELHEIM GROUP
PHAROS GROUP
ASTRAZENECA
2
Sales
Trade
MAT
2013Q2
2,818
LOCAL
LOCAL
LOCAL
MNC
MNC
LOCAL
MNC
LOCAL
LOCAL
LOCAL
MNC
MNC
LOCAL
LOCAL
MNC
LOCAL
LOCAL
MNC
LOCAL
MNC
395
249
179
119
111
105
90
72
71
69
66
60
51
51
50
49
48
47
47
42
Market
Share
MAT
2013Q2
Growth
CAGR
MAT
2013Q2
MAT
2013Q2
100%
11%
13%
14%
9%
6%
4%
4%
4%
3%
3%
3%
2%
2%
2%
2%
2%
2%
2%
2%
2%
2%
1%
17%
16%
16%
10%
8%
17%
-1%
-4%
11%
16%
16%
5%
-3%
16%
23%
9%
7%
20%
5%
12%
Exchange rate: Constant IDR10,583,333,333/OKU YEN
Source: IMS Plus 2013-Q2
15%
15%
12%
20%
13%
17%
4%
11%
13%
11%
10%
9%
14%
9%
28%
7%
11%
20%
14%
9%
Rank
OTC
Sales
Trade
IND TOTAL OTC
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
SOHO GROUP
KALBE GROUP
TEMPO GROUP
PHAROS GROUP
KONIMEX
DEXA MEDICA GROUP
DARYA-VARIA GROUP
GLAXOSMITHKL GRP
LAPI
NOVELL PHARM
BAYER INDONESIA
SANBE
INTERBAT
J&J
MERCK INDONESIA GP
MENSA GROUP
COMBIPHAR GROUP
B.INGELHEIM GROUP
MAHAKAM BETA
FARMA
HISAMITSU PHARMA
Growth
CAGR
MAT
2013Q2
MAT
2013Q2
MAT
2013Q2
MAT
2013Q2
1,892
Status
Market
Share
100%
15%
11%
LOCAL
LOCAL
LOCAL
LOCAL
LOCAL
LOCAL
LOCAL
MNC
LOCAL
LOCAL
MNC
LOCAL
LOCAL
MNC
MNC
LOCAL
LOCAL
MNC
195
179
159
137
102
62
56
54
53
52
40
40
34
31
30
28
27
24
10%
9%
8%
7%
5%
3%
3%
3%
3%
3%
2%
2%
2%
2%
2%
1%
1%
1%
25%
-2%
6%
34%
11%
10%
17%
8%
79%
30%
19%
7%
6%
-1%
7%
-11%
-3%
12%
13%
2%
8%
26%
18%
11%
8%
14%
55%
17%
0%
-2%
8%
9%
6%
-6%
7%
10%
LOCAL
MNC
24
23
1%
1%
68%
38%
45%
26%

4. OTC Market Description
•
At registration, drugs are categorised as one of the following: O (strictly controlled
narcotics); G (prescription-only, obat keras); W (non-prescription, obat bebas terbatas,
with warning label) and F (non-prescription, obat bebas).
–
•
There is a sub-class of G referred to as G2. G2 products are pharmacy-bound, but can be sold
over-the-counter if the pharmacist is sure that the customer needs the drug. These drugs cannot
be advertised to the public.
An alternative method of classification uses different coloured dots on packs:
–
‘Red dot’ products consist of G and G2 products.
–
‘Blue dot’ OTCs (equivalent to Class W) can be purchased without a ––prescription, but only
through licensed drugstores and pharmacies. They have to display warning messages on
packages and can be advertised to consumers.
–
‘Green dot’ OTCs (Class F drugs) are products available without prescription ––in any outlet e.g.
drugstores, supermarkets, peddlers, cigarette kiosks and bookstores. There is no limit to the
quantity of drug purchased and advertising to consumers is permitted.
Only Blue dot
and Green dot
drugs can be
advertised
3 | Click > Insert > Header & Footer | DDMMYY

5. IMS Prognosis 2013 on OTC
• As the pharmacist is commonly the first port of call, there is heavy reliance on over-thecounter (OTC) medicines or under-thecounter prescription drugs, and 30% of the
population uses traditional jamu medicines.
• Growth in the OTC market is strong, and will be driven by the buoyant economy and
expansion of outlets selling these products. Domestic companies in particular will continue to
build up their non-Rx-bound businesses, especially in areas such as herbal medicine
• Vitamins, minerals and nutritional supplements are the largest non-Rx bound
category in sales terms, followed by cough, cold and other respiratory remedies, and then
pain relief.
• Herbal medicines, particularly modern herbal brands, which are encroaching into the
market for conventional OTC medicines, are expected to become an important growth
category. Leading local companies already have herbal lines and more local manufacturers
especially those unable to meet new quality standards for prescription medicines, will branch
out into herbals.
4 | Click > Insert > Header & Footer | DDMMYY

6. OTC & Nutrition Market
Based on our own market category definition, Lifestyle Product (incl Multi Vitamin and Tonic) is the leading category is at 18.8% of share
with +3.8% growth. The other Top category are Herbal and Skin Vitamin which driving the market growth.
+10.3%
2,000.0
1,600.0
MAT 2013Q2 $ Share (%)
+11.6%
1,800.0
Lifestyle
19%
+9.4%
+4.7%
1,400.0
1,200.0
1,000.0
800.0
1,260.2
1,309.9
1,644.1
1,432.4
1,892.0
Skin
Vitamin
5%
OTC
Nutrition
Digestive /
GI
4%
600.0
Others
57%
400.0
200.0
OTC + Nutrition
Lifestyle
Herbal
Skin Vitamin
Digestive / GI
Respi
Laxative
Memory
Others
114.2
129.2
141.2
112.3
2009
0.0
2010
2011
2012 MAT 2013Q2
Sales in OKU YEN
2009
2010
1,374.4
1,439.1
339.4
334.8
109.6
109.4
42.9
51.6
47.6
44.9
34.2
38.6
33.2
32.3
6.0
8.2
761.5
819.4
2011
1,573.7
338.5
123.7
53.2
48.0
45.3
36.6
11.3
917.1
45.2
Share (%)
2012 MAT 2013 Q2 2009
1,756.3
1,937.3
100.0%
350.5
363.9
24.7%
166.2
215.8
8.0%
63.4
101.5
3.1%
59.8
70.4
3.5%
51.9
52.3
2.5%
44.2
51.7
2.4%
15.6
17.5
0.4%
1,004.7
1,064.1
55.4%
5 | Click > Insert > Header & Footer | DDMMYY
Respi
0%
2010
100.0%
23.3%
7.6%
3.6%
3.1%
2.7%
2.2%
0.6%
56.9%
2011
100.0%
21.5%
7.9%
3.4%
3.0%
2.9%
2.3%
0.7%
58.3%
Growth YoY (%)
2012 MAT 2013 Q2 2010
2011
100.0%
100.0%
4.7%
9.3%
20.0%
18.8%
-1.4%
1.1%
9.5%
11.1%
-0.2%
13.0%
3.6%
5.2%
20.2%
3.1%
3.4%
3.6%
-5.7%
6.9%
3.0%
2.7%
12.9%
17.3%
2.5%
2.7%
-2.5%
13.1%
0.9%
0.9%
36.7%
38.4%
57.2%
54.9%
7.6%
11.9%
Laxative
3%
Memory
1%
Herbal
11%
CAGR
2012 MAT 2013 Q2
09-'13
11.6%
10.3%
9.0%
3.5%
3.8%
1.8%
34.4%
29.9%
18.5%
19.2%
60.1%
24.0%
24.7%
17.7%
10.3%
14.5%
0.8%
11.2%
20.7%
17.1%
11.7%
38.3%
12.0%
30.9%
9.6%
5.9%
8.7%

7. OTC – Lifestyle Market (1)
Lifestyle market is dominated and driven by Vitamin subcategory, but still below overall OTC growth. Zooming in, Multivitamins are the top
3 subcategory for Vitamin. Oppositely, Vitamin-Kid suffered negative growth YoY - last year.
SUB-CATEGORY
ATC IV
A11A4
A11B4
A11D4
A11G2
A11E3
A11G1
A11E2
A11D9
A11X9
A11D3
A11E1
A11X2
A11F0
TOTAL OTC - LIFESTYLE
MVIT + MIN OTHERS
MVIT W/O MIN OTHERS
VIT.B1+VIT.B6 &/OR B12
VITAMIN C COMBINATIONS
VITAMIN B COMPLEX OTHERS
VITAMIN C PLAIN
VITAMIN B COMPLEX + VIT C
OTHER VITAMIN B1 COMBS
ALL OTHER VITAMINS
VITAMIN B1 PLAIN
VITAMIN B COMPLEX PLAIN
VIT B6(PYRIDOXINE) PLAIN
VITAMIN B12 PLAIN
A13A2
ALL OTHER TONICS
S01M0
EYE TONICS&EYE VITAMINS
A11B2
A11C3
A11A2
MVIT W/O MIN PAEDIATRIC
VITAMIN A & D COMBS
MVIT + MIN PAEDIATRIC
6 | Click > Insert > Header & Footer | DDMMYY
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Vitamin
Lifestyle - Tonic
Lifestyle - Tonic
Lifestyle - Eye
Lifestyle - Eye
Lifestyle - Kid
Lifestyle - Kid
Lifestyle - Kid
Lifestyle - Kid
Sales in OKU YEN
Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
363.9
100.0%
3.8%
1.8%
59.3
16.3%
12.3%
6.7%
45.4
12.5%
13.0%
0.4%
35.6
9.8%
4.2%
5.9%
29.7
8.2%
22.5%
6.0%
28.1
7.7%
-4.0%
3.2%
20.3
5.6%
-1.8%
1.6%
14.1
3.9%
11.1%
6.3%
11.2
3.1%
5.7%
11.2%
9.1
2.5%
6.7%
37.6%
3.0
0.8%
35.7%
6.2%
2.7
0.7%
6.3%
-3.3%
0.7
0.2%
42.9%
6.9%
0.5
0.1%
97.1%
16.9%
259.8
71.4%
8.8%
5.1%
58.7
16.1%
-10.9%
-8.7%
58.7
16.1%
-10.9%
-8.7%
23.2
6.4%
2.2%
0.4%
23.2
6.4%
2.2%
0.4%
10.1
2.8%
-2.4%
2.8%
9.4
2.6%
-4.7%
7.4%
2.7
0.7%
-10.9%
-0.5%
22.2
6.1%
-4.5%
4.2%

8. OTC – Lifestyle Market (2)
Vitamin products are mostly registered as food supplement product at BPOM (local FDA). This subcategory is heavily advertised, and in
average the product advertisement show the benefit is to increase stamina, boost imunity and relieve muscle/nerves stiffness. The
pacakging range from capsules, chewable/nonchewable tablet, to RTD . The Vitamin products mostly are dominated by Local
manufacturers, even though there are some MNC are competing in this category as well.
Sub-Category
Lifestyle - Vitamin
Lifestyle - Tonic
Lifestyle - Eye
Lifestyle - Kid
Sales in OKU YEN Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2
MAT 2013 Q2
'09-'13
259.8
71.4%
8.8%
5.1%
58.7
16.1%
-10.9%
-8.7%
23.2
6.4%
2.2%
0.4%
22.2
6.1%
-4.5%
4.2%
Popular Products
MAT 2013 Q2
Vit B1+B6+B16
Neurobion (MCK)
OKU YEN 14.3
CAGR +3.0 %
Vit C Combination
Cerebrovit X-Cel (TCN)
OKU YEN 15.9
CAGR +6.9%
Multivitamin Kid
Curcuma Plus (SHO)
OKU YEN 9.6
CAGR -7.1%
7 | Click > Insert > Header & Footer | DDMMYY
Vit B Complex
Hemaviton (TFC)
OKU YEN 8.9
CAGR +3.6%
Other Vit B+Comb
Cerebrovit X-Cel (KLB)
OKU YEN 2.0
CAGR +10.7%
Vitamin C Plain
Vitacimin (TAK)
OKU YEN 7.3
CAGR +5.5%

9. OTC – Herbal
Herbal category recorded a very high growth at +29.9% yoy and 5 yrs CAGR at +18.5%, this category has been the raising category over
the past years. Many of local companies are expanding to launch Herbal products. The usage of Herbal products range from boosting
stamina, relieving sleep disorder, and hormonal BPH product. The existing products have been showing positive growth due to affordable
price, wide availability, heavy advertisment and high acceptability by most Indonesian. All Herbal products are manufactured and
registered by Local products, as their original product development.
SUB-CATEGORY
ATC IV TOTAL OTC - HERBAL
V03X0 ALL OTH.THERAPEUTIC PRDS
Herbal - Others
A05B0 HEPAT PROTECT-LIPOTROPICS Herbal - Lipo
C10B0 ANTI-ATHEROMA NATRL ORIG
Herbal - Anti Atheroma
G04C9 BPH PRODUCTS OTHER
Herbal - BPH
N05B5 HERB HYPNOTICS/SEDATIVES Herbal - Hypno
A15A0 APPETITE STIMULANTS
Herbal - Appetite
N06A2 ANTIDEPRESSANTS, HERBALS Herbal - Antidepressant
MAT 2013 Q2
Sales in OKU YEN Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
215.8
100.0%
29.9%
18.5%
186.9
86.6%
30.4%
19.6%
18.2
8.4%
13.2%
10.0%
4.9
2.3%
149.1%
46.9%
3.1
1.5%
20.2%
9.5%
1.9
0.9%
67.9%
6.3%
0.8
0.4%
-29.7%
-4.9%
0.0
0.0%
-14.3%
-10.1%
Popular Products
Herbal - Lipo
8%
Herbal - Anti
Atheroma
2%
All Oth Thera Prod
Imboot (SHO)
OKU YEN 35.5
CAGR +18.7%
Hepa Protect-Lipo
Bio Curliv (SHO)
OKU YEN 3.4
CAGR +90.5%
Herbal - BPH
2%
Herbal Others
87%
Herbal Hypno
1%
Herbal Herbal Antidepressa
Appetite
nt
0%
0%
8 | Click > Insert > Header & Footer | DDMMYY
Herb Hypnotic
Lelap (SHO)
OKU YEN 1.9
CAGR +6.5%
BPH Product
Batuin (KM7)
OKU YEN 2.2
CAGR +12.5%

10. OTC – Skin Vitamin Market
Only 2 subcategories: Dermatological and Vitamin E plain, even though both base ingredients are the same (Vitamin E). The growth has
been tremendous at +60.1% yoy and 5 yrs CAGR at +24.0%. Some of the products are registered as food supplement at BPOM – except
for topical product. The benefit as promoted, is to keep skin healthy, rejuvenate skin to be younger looks, and increase skin moist through
internal system. The packaging range from tablet to topikal cream – some topikal product is promoted to erase skin scars or sun burn (i.e
Dermatix). One of the biggest product is Nourish Skin from Pharos. It targets young-adult female as to keep their skin shiny and healthy.
It’s heavily advertised and available at the top shelf display in all Pharos’ own retail pharmacy chain – Century.
ATC IV
D11A0
A11X3
TOTAL OTC - SKIN
OTHER DERMATOLOGICALS
VITAMIN E PLAIN
Sales in OKU YEN Share (%)
Growth YoY (%)
CAGR
SUB-CATEGORY MAT 2013 Q2
MAT 2013 Q2
MAT 2013 Q2
'09-'13
101.5
100.0%
60.1%
24.0%
Skin - Others
72.8
71.7%
75.3%
22.9%
Skin - Vit E
28.7
28.3%
31.2%
27.2%
Popular Products in Skin Category
Vitamin E Plain
Nature-E (D.V)
OKU YEN 11.8
CAGR +14.8%
Vitamin E Plain
Ever E (KOX)
OKU YEN 9.8
CAGR +178.8%
9 | Click > Insert > Header & Footer | DDMMYY
Other Dermato
Nourish Skin (P-I)
OKU YEN 43.6
CAGR +14.2%
Other Dermato
Dermatix (T5F)
OKU YEN 5.7
Growth ’12-13 ,+58.2%

11. OTC – Digestive / GI Market
GI digestive market is mostly dominated by Anti-Diarrhea products. The Anti-Diarrhea subcategory is one of the most promising
subcategory due to high incidence rate in Indonesia. There are two product base ingredients: natural (probiotic & herbal) & chemical.
Probiotic is widely used for toddlers diarrhea case, as it’s safe and convenience to be consumed (in powder or liquid form). However, most
of the Probiotic pricing is not cheap – in average. The cheaper base ingredient is Attapulgite, a herbal based, and also widely popular
among rural population, mostly sold in 4 tablets sachet and widely available at street stalls.
Sales in OKU YEN Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
TOTAL OTC - DIGESTIVE / GI
70.4
100.0%
60.1%
24.0%
ANTIDIARR MICRO-ORGANISMS
Digestive / GI - Anti Diarrhea
25.3
35.9%
50.1%
26.2%
INTEST ADSORBENT ANTIDIA
Digestive / GI - Anti Diarrhea
20.9
29.7%
2.2%
6.1%
DIGESTIVES INC.ENZYMES
Digestive / GI - Enzym
7.5
10.6%
7.4%
2.6%
OTHER ANTIDIARRHOEALS
Digestive / GI - Anti Diarrhea
5.0
7.1%
-15.0%
0.6%
OTH STOMACH DISORDER PREP Digestive / GI - Stomach Disord
4.5
6.4%
22.4%
9.4%
STOMATOLOGICALS
Digestive / GI - Stomato
2.9
4.1%
54.7%
0.8%
ALL OTHER ANTIULCERANTS
Digestive / GI - Antiulcerant
1.6
2.3%
-19.0%
-3.5%
PLAIN ANTIFLATULENTS
Digestive / GI - Antiflatulent
1.5
2.1%
34.7%
10.6%
ANTI-INFECTIVE ANTIDIARR
Digestive / GI - Anti Diarrhea
0.5
0.7%
-5.4%
22.3%
ANTIFLATULENTS + OTHERS
Digestive / GI - Antiflatulent
0.5
0.7%
428.0% #DIV/0!
H2 ANTAGONISTS
Digestive / GI - Antiulcerant
0.3
0.4%
-26.2%
-10.5%
SUB-CATEGORY
ATC IV
A07F0
A07B0
A09A0
A07X0
A02C0
A01A0
A02B9
A02A2
A07A0
A02A7
A02B1
MAT 2013 Q2
Digestive /
Digestive /
GI - Enzym
11%
GI Stomato
4%
Digestive /
GI Antiflatulen
t
3% Digestive /
GI Antiulceran
t
3%
Digestive /
GI Stomach
Disord
6%
Digestive /
GI - Anti
Diarrhea
73%
10 | Click > Insert > Header & Footer | DDMMYY
Popular Products
Antidiarr Micro Organi
Lacto B (NLL)
OKU YEN 9.9
CAGR +11.8%
Antidiarr Adsorbent
Neo Entrostop (KLB)
OKU YEN 7.5
CAGR +6.3%
Anti diarrhe Other
Diapet (SHO)
OKU YEN 4.3
CAGR -3.3%
Stomach Disorder
Fucoidan (SHO)
OKU YEN 3.3
CAGR +6.5%

12. OTC - Respiratory
The growth of Respiratory category is lower than others, at +0.8% yoy, even though its 5 yrs CAGR is at +11.2%. The product pack ranges
from Tablets, Topikal, and Drops and Syrup. The top biggest subcategories are Allergic, Asthma and Cough & Cold. This category, in
average, is promoted through electronic media; TV and radio, and printed media. Many reason of its slowing down sales value due to
decreasing spending on advertising from local companies. However this category is not seasonal, compared to European countries, the
incidence rate is almost stable over the seasons in Indonesia.
SUB-CATEGORY
ATC IV
R04A0
R05D1
R05F0
R03B2
R02A0
R01B0
R01A7
R01A9
R03X2
TOTAL OTC - RESPIRATORY
CHEST RUBS & INHALANTS
ANTITUSSIVES PLAIN
OTHER COUGH & COLD PREPS
XANTHINES,SYSTEMIC
PHARYNGEAL PREPARATIONS
SYSTEMIC NASAL PREPS
NASAL DECONGESTANTS
OTH TOPICAL NASAL PREPS
ALL OTH A-AS & COPD, SYS
MAT 2013 Q2
Respi Nasal
14%
Respi Alergic
35%
Respi
Respi
Respi
Respi
Respi
Respi
Respi
Respi
Respi
- Asthma
- Antitusive
- Cough & Cold
- Alergic
- Alergic
- Nasal
- Nasal
- Nasal
- Asthma
Sales in OKU YEN Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
52.3
100.0%
0.8%
11.2%
11.4
21.9%
46.1%
15.9%
10.1
19.4%
-16.6%
18.0%
10.1
19.2%
42.0%
26.1%
7.7
14.8%
-40.4%
-1.4%
7.1
13.5%
7.2%
4.6%
3.6
7.0%
4.5%
2.4%
1.3
2.4%
17.0%
7.4%
0.9
1.8%
34.1%
27.6%
0.0
0.0%
4800.5%
-14.8%
Popular Products
Respi Asthma
27%
Respi Cough &
Cold
24%
11 | Click > Insert > Header & Footer | DDMMYY
Chest Rubs & Inhalant
Transpulmin (T5F)
OKU YEN 4.4
CAGR +12.5%
Other Cough & Cold
Laserin (MEC)
OKU YEN 7.5
CAGR +32.2%
Xanthines, systemic
Neo Napacin (KOX)
OKU YEN 4.0
CAGR -12.5%
Systemic Nasal Preps
Woods Pepermint
(SKA)
OKU YEN 3.2
CAGR +9.4%

13. OTC – Laxative
Laxative category grew at +17.1% yoy and 5 yrs CAGR at +11.7%.. The packs range from tablets to enemas. There is one heavily
advertised product; Laxing by Soho, is a herbal based product, the latet CAGR is only at +0.6%.
Sales in OKU YEN Share (%)
Growth YoY (%) CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
TOTAL OTC - LAXATIVE
51.7
100.0%
17.1%
STIMULANT LAXATIVES
Laxative - General
14.5
28.0%
15.3%
SLIMMING PREPARATIONS
Laxative - Slimming
13.4
25.9%
1.0%
LAXATIVE ENEMAS
Laxative - General
13.2
25.5%
28.0%
BULK-FORMING LAXATIVES
Laxative - General
6.5
12.6%
38.5%
OSMOTIC LAXATIVES
Laxative - Ethical
2.7
5.2%
15.5%
OTHER-NON-THERAPEUTIC
Laxative - Weight Loss
1.1
2.1%
43.4%
FAECAL SOFTENING LAXATIV Laxative - General
0.4
0.7%
38.4%
SUB-CATEGORY
ATC IV
A06A2
V06A0
A06A4
A06A3
A06A6
V07A0
A06A1
11.7%
5.3%
7.6%
26.4%
14.6%
11.3%
11.9%
70.0%
Popular Products
MAT 2013 Q2
Stimulant
Dulcolax (B.I)
OKU YEN 7.6
CAGR +12.1%
Laxative Weight
Loss
Laxative 2%
Ethical
5%
Laxative Slimming
26%
Stimulant
Laxing (SHO)
OKU YEN 6.6
CAGR +0.6%
Laxative General
67%
12 | Click > Insert > Header & Footer | DDMMYY
Enema
Microlax (P-I)
OKU YEN 12.9
CAGR +27.0%

14. OTC – Memory Preserve
Memory preserve category is smaller than other category in terms of sales value, but with high growth at +12.0% yoy and 5 yrs CAGR at
30.9%. Most of the products are promoted to increase memory and avoid ageing memory capacity.
SUB-CATEGORY
ATC IV
N06D0
C04A1
N06E0
TOTAL OTC - MEMORY
NOOTROPICS
Memory - Nootropic
CEREB.&PERI.VASOTH.EXC CA Memory - Cerebral
NEUROTONIC & MISCELL
Memory - Neurotonic
Sales in OKU YEN Share (%)
Growth YoY (%)
CAGR
MAT 2013 Q2
MAT 2013 Q2 MAT 2013 Q2
'09-'13
17.51
100.0%
12.0%
30.9%
7.81
44.6%
18.7%
80.0%
7.47
42.7%
13.4%
19.4%
2.22
12.7%
-9.7%
9.4%
MAT 2013 Q2
Popular Products
Memory Neurotonic
13%
Memory Nootropic
44%
Memory Cerebral
43%
13 | Click > Insert > Header & Footer | DDMMYY
Nootropic
Neulin (FPP)
OKU YEN 6.8
CAGR +72.9%
Cerebral
Soholin (SHO)
OKU YEN 2.6
CAGR +64.2%

15. Age Group Population
Indonesian population per 2010 national census grew at 1.1% YoY. The population pyramid has shown a shift to a bigger young to middle
age group – which resulted to the increasing productive age group between 24 to 54 y.o. The split between Male:Female is almost
equal, except a slightly higher in Female Ageing Well group
Toddler
10%
Ageing
well
11%
Kids
10%
Mature
18%
Parentho
od
8%
Young
Parent
8%
Population
Grouping
Toddler
Kids
Teens
Teens adult
Young adult
Early jobber
Young Parent
Parenthood
Mature
Ageing well
Total
Age Range
0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-54
55+
# of Population
22,678,702
23,253,480
22,671,081
20,880,734
19,891,633
21,310,443
19,830,685
18,505,131
42,127,155
26,492,282
237,641,326
14 | Click > Insert > Header & Footer | DDMMYY
Teens
9%
Early
jobber
9%
Teens
adult
9%
Young
adult
8%
% based on total age group
% based on Gender
Male
Female ALL
Male
Female ALL
10%
9%
10%
51%
49%
100%
10%
10%
10%
51%
49%
100%
10%
9%
10%
51%
49%
100%
9%
9%
9%
51%
49%
100%
8%
8%
8%
50%
50%
100%
9%
9%
9%
50%
50%
100%
8%
8%
8%
50%
50%
100%
8%
8%
8%
50%
50%
100%
18%
18%
18%
50%
50%
100%
11%
12%
11%
48%
52%
100%
100%
100%
100%
50%
50%
100%
Source: sp2010.bps.go.id

16. Indonesia Socio Economic Class - Nielsen & BCG report
Nielsen, the leading global market data provider company, publishes yearly consumer segmentations, called Socio Economic Class (SEC)
and the single measure/ criteria is heavily based on routine Monthly Household Expenditure (MHE). It’s widely used by consumer goods
company or any marketer which targeting consumer/ patient base. It shows the level of economic buying power, from the lowest E class
(those who spends MHE below IDR 700K per month to the highest A class (> IDR 3mio per month). From the past 3 years consecutive
data below, it tells us that Indonesian middle economic classes (AtoC1) are increasing at +6% average, correlates to the economic growth
at +6% yoy. This is also aligned with the latest Boston Consulting Group’s (BCG) report and World Bank’s report on Indonesian middle
class
BCG’s Report
Nielsen’s SES
9%
17%
25%
12%
3%
8%
14%
22%
27%
28%
+5%
23%
23%
25%
18%
8%
2010
16% +9%
14%
8%
E IDR < 700.000
D IDR 700.001 1.000.000
C2 IDR 1.000.001
- 1.500.000
C1 IDR 1.500.001
- 2.000.000
B IDR 2.000.001 3.000.000
A IDR >
3.000.000
+6%
2011
2012
15 | Click > Insert > Header & Footer | DDMMYY
World Bank’s Report
– from the
economist.com